Black Friday 25% off both GutID tests, through Cyber Monday. No code needed. 25% off both tests, through Cyber Monday Shop the sale
Free shipping both waysHSA/FSA eligible in the USResults 3–4 weeks after lab receipt

GI-MAP vs. GI360: How Two Comprehensive Stool Tests Compare

GI-MAP® and GI360™ both give practitioners a wide-ranging stool workup, but they get there by different routes. GI-MAP runs quantitative PCR (qPCR) on a single stool sample, while the Doctor's Data GI360 combines multiplex PCR (summarized as a Dysbiosis Index and a Diversity score) with culture and MALDI-TOF identification, susceptibility testing, microscopy for parasites and stool chemistries, over one to three collection days. Neither lab publishes a price; Diagnostic Solutions Laboratory (DSL) files insurance and Medicare claims for GI-MAP, while Mosaic Diagnostics, which offers GI360, provides superbills instead of filing claims.

Both panels read the commensal microbiome through targets chosen in advance, from GI-MAP's named qPCR assays to GI360's 45-plus PCR analytes. GutID sees the entire bacterial ecosystem instead: Titan-1™ long-read sequencing measures every bacterium present, to species, including novel and uncharacterized organisms, and more than 30 peer-reviewed publications use the approach behind it. GutID Pro adds 65 targeted markers from the same collection, so the ecosystem and a targeted panel arrive in one report.

This guide is for practitioners choosing between the two panels. It also covers a common naming question: GI360 is a Doctor's Data stool profile that, at time of writing (October 2026), is listed by and can be ordered through Mosaic Diagnostics (MosaicDX). For Doctor's Data's other stool panels, see our Doctor's Data stool test vs. GI-MAP guide.

GI-MAP vs. GI360 at a glance

Attribute GI-MAP® (Diagnostic Solutions Laboratory) GI360™ (Doctor's Data, offered through MosaicDX) GutID Pro
Who orders it A healthcare practitioner A practitioner; MosaicDX does not accept direct patient orders Approved clinicians in the US, for patients 18 and over
Method qPCR targeting each organism's DNA Multiplex PCR, culture with MALDI-TOF identification, microscopy, biochemical assays and susceptibility testing Titan-1 long-read ribosomal sequencing of every bacterium in the sample, plus eight included lab panels run by a CLIA laboratory
What it measures Bacterial, viral and parasitic pathogens; H. pylori plus virulence and resistance genes; keystone, opportunistic and inflammation-linked bacteria; yeast and fungi; CMV and EBV; protozoa and worms; digestion, immune and inflammation markers More than 45 microbiome analytes with a Dysbiosis Index and Diversity score; PCR for 14 pathogens; ova-and-parasite microscopy; cultured bacteria and yeast with susceptibilities; stool chemistries The whole bacterial community to species, with relative abundance and diversity; 65 targeted markers covering enteric bacteria, enteric viruses, parasites, Candida species, calprotectin, pancreatic elastase-1, occult blood, H. pylori antigen and 31 commensal and dysbiotic markers; gut-brain, gut-immune, gut-metabolism and gut-heart axes
Sample One stool sample, shipped at room temperature Stool over one to three days (MosaicDX recommends three); some vials refrigerated, one frozen One stool collection into two tubes
Results time 7–10 business days (DSL's current figure) Doctor's Data estimates 6–8 days; MosaicDX estimates 1–2 weeks 3–4 weeks
Price and billing Not published; DSL files claims with primary insurance and Medicare No published price; MosaicDX does not file claims and provides superbills on request Not published; clinicians sign in for pricing
New York Not available for ordering Not offered Not available
Best suited to Organism-focused questions from one collection, with insurance billing available Cases where cultured isolates and susceptibility results are wanted alongside PCR and microscopy Seeing the entire bacterial ecosystem, with targeted markers in the same kit and report

How GI-MAP works

GI-MAP is a DNA-based panel. According to DSL, its qPCR assays target the DNA of each organism tested, covering parasites, bacteria, H. pylori, fungi and more, and DSL presents GI-MAP as a diagnostic tool. The report starts with bacterial, parasitic and viral pathogens, then H. pylori, which is reported with eight virulence-factor targets and with resistance genes for clarithromycin, amoxicillin, fluoroquinolones and tetracycline. Commensal and keystone bacteria, dysbiotic and overgrowth organisms, inflammatory and autoimmune-related bacteria, yeast and other fungi, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), and finally protozoa and worms make up the rest of the organism sections.

A block of intestinal health markers rounds it out: calprotectin, eosinophil activation protein, secretory and anti-gliadin IgA, steatocrit, elastase-1, β-glucuronidase and a fecal immunochemical test for occult blood. Practitioners can add zonulin, fecal gluten peptide or a universal antibiotic resistance genes panel that DSL says covers 55 genetic elements across 10 antibiotic classes. Our guide to what a GI-MAP tests for goes section by section.

How GI360 works

Doctor's Data describes GI360 as building on its Comprehensive Stool Analysis (CSAP) by adding a multiplex PCR platform. That platform measures more than 45 targeted bacterial analytes across six phyla and condenses them into a Dysbiosis Index and a Diversity score, each on a 1–5 scale. A second PCR panel covers 14 pathogenic bacteria, viruses and parasites, among them Campylobacter, C. difficile, Shiga toxin-producing E. coli, Salmonella, Shigella, Cryptosporidium, Giardia, norovirus and rotavirus.

The rest of the profile relies on culture, microscopy and chemistry. Bacteria and yeast are cultured and identified by MALDI-TOF mass spectrometry, and Doctor's Data says it can identify more than 1,600 genera and species this way. Cultured pathogenic and dysbiotic bacteria and all cultured yeast are tested for susceptibility to antibiotics and natural or botanical agents. Microscopy provides a full ova-and-parasite exam, and the stool chemistries cover elastase, fat and carbohydrates, calprotectin, lactoferrin, lysozyme, secretory IgA, short-chain fatty acids, pH, occult blood and β-glucuronidase.

Collection takes more planning than a single-sample kit. MosaicDX recommends three collection days at least 12 hours apart and Monday-to-Wednesday shipping, while Doctor's Data leaves one to three days to the clinician, so follow the kit from the company you order through. Both have patients refrigerate some vials, freeze one, and pause antibiotics, antiparasitics, antifungals, probiotic supplements, proton pump inhibitors and bismuth for two weeks before collection.

Key differences that affect test choice

Molecular only vs. molecular plus culture. GI-MAP reports organisms as qPCR results. GI360 adds culture, so its report includes identified isolates with susceptibility results. GI-MAP reports resistance genes instead: for H. pylori in the core report, and across 10 antibiotic classes with the universal add-on.

Parasites. GI-MAP detects protozoa and worms by qPCR. GI360 pairs PCR for Cryptosporidium, Entamoeba histolytica and Giardia with a microscopic ova-and-parasite exam.

Microbiome summary. GI-MAP lists commensal, keystone and opportunistic bacteria individually, with a Firmicutes:Bacteroidetes ratio. GI360 adds two summary scores to its 45-plus analyte profile.

H. pylori. GI-MAP's core report includes H. pylori with virulence factors and resistance genes. Doctor's Data lists an H. pylori antigen test as a GI360 add-on.

Viruses. Both panels include adenovirus 40/41 and norovirus. GI360's pathogen PCR also includes rotavirus A, and GI-MAP also reports cytomegalovirus and Epstein-Barr virus.

Billing. DSL bills primary insurance for GI-MAP as an out-of-network lab and is a participating Medicare provider. MosaicDX stopped filing claims on patients' behalf on March 1, 2025, and is not a Medicare participating provider. Neither panel is offered in New York.

When GI-MAP is the right choice

  • You want a DNA-based, quantitative read on pathogens, H. pylori (with virulence factors and resistance genes), opportunistic bacteria, fungi and parasites.
  • The patient needs a single collection that can be completed in one sitting.
  • The patient wants the lab bill submitted to commercial insurance or traditional Medicare, provided the ordering clinician is enrolled in PECOS for Medicare claims.

When GI360 is the right choice

  • Cultured isolates and susceptibility results, including natural and botanical agents, would shape your plan.
  • You want PCR, culture and microscopy reported side by side, with a dysbiosis score and a full set of stool chemistries.
  • The patient can manage a multi-day collection with cold storage and, when ordering through MosaicDX, is comfortable paying up front and filing a superbill.

Patients with a suspected acute infection, or with red-flag symptoms like blood in the stool, unexplained weight loss, fever, or severe or persistent diarrhea, should see a clinician promptly for diagnostic testing.

When GutID Pro is the better choice

  • You want the whole community, not 45 targets. Titan-1 identifies and measures every bacterium in the sample to species, with relative abundance, including organisms that have no species name yet.
  • You want a single collection. Pro uses one collection split into two tubes, rather than the three collection days MosaicDX recommends for GI360.
  • You want H. pylori and stool markers included. H. pylori stool antigen, a GI360 add-on, comes with every Pro kit, as do calprotectin, pancreatic elastase-1, fecal occult blood, C. difficile toxin NAAT and a GI panel of enteric bacteria, enteric viruses, parasites and Candida species.

One report brings back the ecosystem, the 65 markers and the gut-brain, gut-immune, gut-metabolism and gut-heart axes. Pro is ordered and interpreted by approved clinicians for patients 18 and over anywhere in the US except New York State: request a clinician account.

Why GutID sees more

GI-MAP runs qPCR assays for named organisms, and GI360's microbiome profile is a set of more than 45 PCR targets across six phyla. Lists are efficient for checking what you suspect, but an organism that isn't on one goes undetected. Titan-1 reads what is actually in the sample, so it sees the entire bacterial ecosystem: diversity, balance, each species' relative abundance and how the community changes between tests.

The difference is length. A short-read 16S test sees a few hundred bases of each bacterium's ribosomal DNA; Titan-1 sees about 2,500 in one continuous fragment of the full 16S gene, the ITS and the start of 23S, read in repeated passes and combined into a consensus. GutID's own classifier identifies organisms from that whole read rather than matching short markers to a fixed database, so even unnamed organisms are separated and quantified.

More than 30 peer-reviewed publications use the long-read approach behind Titan-1, in journals including Communications Biology, ISME Communications and Scientific Reports (see the science and the evidence). When Gehrig and colleagues compared sequencing approaches on clinical-trial samples (Microbial Genomics, 2022), every method identified the study's active-ingredient strain, with higher detection confidence for long-read methods, and only long-read 16S-ITS-23S profiling, compared with short-read 16S, provided strain-level community resolution.

Targeted answers come from the same collection: a CLIA laboratory runs GutID Pro's 65 markers on a second tube, reported with the ecosystem, while Titan-1 samples are processed by a CLIA laboratory in the United States. See the GutID sample report.

Frequently asked questions

What is the GI360 stool test?

GI360 is Doctor's Data's comprehensive stool profile. It combines multiplex PCR for more than 45 microbiome analytes and 14 pathogens with culture and MALDI-TOF identification, susceptibility testing, ova-and-parasite microscopy and stool chemistries, and it reports a Dysbiosis Index and a Diversity score.

Is GI360 from Doctor's Data or Mosaic Diagnostics?

Both names appear. Doctor's Data, Inc. performs the test and still offers GI360 directly, while Mosaic Diagnostics (MosaicDX) lists the GI360 profiles, takes orders through its portal and hosts the sample report, which names Doctor's Data as the laboratory.

How much does the GI 360 cost?

Neither MosaicDX nor Doctor's Data publishes a GI360 price on the pages we reviewed at time of writing, and MosaicDX directs patients to their healthcare provider for pricing. MosaicDX does not file insurance claims for patients, provides a superbill after the test is paid in full, accepts HSA and FSA cards and treats Medicare patients as self-pay. For the other side of the comparison, see our guide to GI-MAP test cost.

How does GI360 compare with GI Effects?

Both pair PCR with culture, MALDI-TOF identification and microscopy. GI360 summarizes its multiplex PCR microbiome results as a Dysbiosis Index and Diversity score, while Genova's GI Effects® Comprehensive Profile uses 16S rRNA qPCR on 24 commensal genera and species and reports inflammation-associated and methane dysbiosis scores. Our Gut Zoomer vs. GI Effects vs. GI360 comparison covers the details.

Is GutID better than GI-MAP or GI360?

For seeing the entire bacterial ecosystem, yes. GI360's microbiome profile and GI-MAP's commensal section are built from chosen targets, while Titan-1 identifies and measures every bacterium in the sample, including organisms without a species name, reading 5–10 times more ribosomal DNA per bacterium than short-read 16S. More than 30 peer-reviewed publications back the approach, and GutID Pro adds 65 targeted markers to the same kit.

What does GutID Pro add?

Pro keeps the full Complete Microbiome Assessment and adds 65 markers: 31 commensal and dysbiotic markers with reference ranges; quantitative calprotectin, pancreatic elastase-1 and fecal occult blood; H. pylori stool antigen; and a GI panel of twelve enteric bacteria, six enteric viruses, six parasites and six Candida species that also reports C. difficile toxin NAAT. A CLIA laboratory runs them on a second tube from the same collection. Patients can't buy Pro directly, so they should ask their clinician.

Sources

  1. GI-MAP — Diagnostic Solutions Laboratory (accessed October 30, 2026)
  2. GI-MAP Sample Report — Diagnostic Solutions Laboratory (accessed October 30, 2026)
  3. Billing Policies for Patients — Diagnostic Solutions Laboratory (accessed October 30, 2026)
  4. GI360™ Profile — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  5. Sample Report GI360 — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  6. Comprehensive Stool Analysis and GI360 Profile Collection Instructions — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  7. How Our Payment Methods and Procedures Work — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  8. Ordering Labs FAQ — Mosaic Diagnostics (MosaicDX) (accessed October 30, 2026)
  9. GI360™ Frequently Asked Questions — Doctor's Data (accessed October 30, 2026)
  10. GI360 Stool Profile — Doctor's Data (accessed October 30, 2026)
  11. Comprehensive Stool Analysis + Parasitology and GI360 Collection Instructions — Doctor's Data (accessed October 30, 2026)
  12. GI Effects® Stool Profiles — Genova Diagnostics (accessed October 30, 2026)
  13. Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data (Gehrig et al., 2022) — Microbial Genomics (accessed October 30, 2026)

GutID provides wellness and educational insights and is not a diagnostic test. GI-MAP®, GI360™ and GI Effects® are trademarks of their respective owners. GutID is not affiliated with Diagnostic Solutions Laboratory, Doctor's Data, Mosaic Diagnostics or Genova Diagnostics.

This article is for education and is not medical advice. GutID provides wellness and educational insights and is not a diagnostic test.

Read two real sample reports.

Two full reports from one de-identified person, before and after an intervention, sent to your inbox.